JP2009215274A - Powdery hair growth agent applied to various spots of body except head - Google Patents

Powdery hair growth agent applied to various spots of body except head Download PDF

Info

Publication number
JP2009215274A
JP2009215274A JP2008100840A JP2008100840A JP2009215274A JP 2009215274 A JP2009215274 A JP 2009215274A JP 2008100840 A JP2008100840 A JP 2008100840A JP 2008100840 A JP2008100840 A JP 2008100840A JP 2009215274 A JP2009215274 A JP 2009215274A
Authority
JP
Japan
Prior art keywords
hair
hair growth
head
agent
except head
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008100840A
Other languages
Japanese (ja)
Inventor
Kenji Iwamoto
賢二 岩本
Nahotoshi Fujikawa
多布利 藤川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANBUREN KK
Original Assignee
SANBUREN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SANBUREN KK filed Critical SANBUREN KK
Priority to JP2008100840A priority Critical patent/JP2009215274A/en
Publication of JP2009215274A publication Critical patent/JP2009215274A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To bring formulation of an effective hair growth agent which is usually liquid to be a powdery agent and to be applicable to spots except head, and absorption of active ingredients and continuous daily use to be easy. <P>SOLUTION: The powdery agent is prepared by blending a carrot foliage extract and a Schisandra chinensis extract which activate and promote adrenocortical function into the hair growth agent instead of blending adrenocortical hormone which improves protection of the hair from being thinning. The agent is brought to be applied to spots except head having high rate of percutaneous absorption to obtain simplicity in use and higher effect. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

本発明は、頭部以外の身体部位に適用する育毛効果粉末剤に関する。The present invention relates to a hair-growth effect powder applied to a body part other than the head.

頭髪の薄毛化は成人男性の約40〜50%にみられ、兆しは20歳代後半にあらわれて加齢と共に進行する。原因は、遺伝と男性ホルモンにあるとされるため(参考文献1)対策が難しく、長い間多くの男性のストレス源となり続けている。そのため、現在唯一の対処法である育毛剤の利用も、多種多数の市場品の何れもが確かな効果をあげ得ないでいる。それは、現行育毛剤配合成分(頭皮の緊張緩和や血行促進成分)が、頭髪劣化原因に必ずしも結びついていないことにもよる。Thinning of the hair is seen in about 40-50% of adult males, and signs appear in the late 20s and progress with age. The cause is considered to be inheritance and male hormones (Reference 1), which is difficult to take countermeasures and has long been a source of stress for many men. For this reason, the use of hair restorer, which is currently the only countermeasure, has not been able to produce a certain effect in any of a large number of products on the market. This is because the current hair-growth compounding ingredients (scalp tension relief and blood circulation promoting ingredients) are not necessarily linked to the cause of hair degradation.

このような情勢の中、1979年、アメリカFDAの認可であるピペリジノピリミジン誘導体の血管拡張薬ミノキシジルが、その服用者の約80%に多毛、軟毛の硬毛化、毛髪径増大をもたらすことが見出され、育毛剤への応用がはかられた(参考文献2)。しかしこれは、医薬品としての承認であるため利用に制約があり、効果も6ヶ月間の使用で中等度改善が27.3%(プラセボで15.7%)と低減した(参考文献3)。これは、頭部への外用と内服の場合との違いによると考えられる。Under such circumstances, in 1979, the US FDA approved piperidinopyrimidine derivative vasodilator Minoxidil brings about about 80% of the users to have hairy, soft hair, and hair diameter increase. Was found and applied to hair restorer (reference document 2). However, since this is an approval as a pharmaceutical product, there are restrictions on its use, and the effect has also been reduced to a modest improvement of 27.3% (15.7% with placebo) after 6 months of use (Reference 3). This is thought to be due to the difference between external application to the head and internal use.

因みに前記参考文献2によれば、ミノキシジルと同様の医原性多毛をきたすものとして副腎皮質ホルモンが挙げられている。しかしこれは、医薬品としての利用以外は認められていない。Incidentally, according to the above-mentioned Reference Document 2, an adrenal cortex hormone is cited as one that causes iatrogenic hirsutism similar to minoxidil. However, this is not allowed except for medicinal use.

頭髪薄毛化に対する現市場育毛剤の全ては、適用部位を頭皮頭髪等頭部とする液剤であるが、液剤にしたミノキシジルを頭部に塗布した場合での効果発現低下は、成分吸収の遅さにもよると考えられる。又、吸収の遅速は適用部位により差があって、例えば、副腎皮質ホルモンの場合、その経皮吸収率は前腕屈側部を1とした場合、頭部は3.5倍、腋下は3.6倍、陰のう部は42倍である(参考文献4)。All of the current market hair growth agents for hair thinning are liquids with the application site as the head of scalp, hair, etc., but when the minoxidil applied to the head is applied to the head, the effect onset is slow due to slow absorption of ingredients. It is thought that it depends on. In addition, the slow speed of absorption varies depending on the application site. For example, in the case of corticosteroid, the transdermal absorption rate is 3.5 times for the head when the forearm flexion side is 1, and 3 for the armpit. .6 times, shadow area is 42 times (Reference 4).

頭部への液状育毛剤の塗布は、普通多量頻回が勧められている。しかし、一般的には、1回1mlを1日2回が標準とされる(参考文献3)。衣類の汚れ防止や整髪の必要もあり、頭部適用の手間も決して少なくないのである。Application of a liquid hair restorer to the head is usually recommended in large quantities. However, in general, 1 ml at a time is standard twice a day (Reference 3). There is also a need to prevent clothes from getting dirty and hairstyling.

参考文献1Reference 1

「毛髪を科学する」岩波化学ライブラリー61、P…81"Science of hair" Iwanami Chemical Library 61, P ... 81

参考文献2Reference 2

「この薬のこの副作用」メディカル・ライフ、P…144"This side effect of this medicine" Medical Life, P ... 144

参考文献3Reference 3

「RiUP・リアップ解説書」〜大正製薬(株)"RiUP / Reup Manual"-Taisho Pharmaceutical Co., Ltd.

参考文献4Reference 4

「ステロイド軟膏の標準的な使い分け」日本薬剤師会雑誌59巻6号、P…103“Standard use of steroid ointment” Journal of the Japanese Pharmacists Association Vol. 59, No. 6, P… 103

従来、男性の頭髪薄毛化改善に利用されてきた頭皮頭髪適用の液剤は、頭皮の緊張緩和成分や血行促進成分配合で軌を一にする。しかし、毛生結果についてはほとんど不分明であったりするため、製品としての被利用期間もそれぞれ長続きするもではなかった。頭皮の緊張緩和については、薄毛化していない側頭部頭皮を薄毛化している前頭部等に移すと薄毛化がみられなくなることから、薄毛は頭皮の緊張によるものではないことが明らかになった(参考文献1、P…89)。血行促進については、経皮吸収薬物量の吸収過程での分解や辛うじて血管に到達したものも、忽ち血流で霧消することから毛生に寄与すべき血行促進成分による実質的効果は得難いとされている(参考文献5)。Conventionally, liquids for scalp and scalp hair that have been used to improve thinning of men's hair have the same balance with components for relaxing scalp tension and blood circulation. However, the results of hair growth are almost unclear, so the period of use as a product did not last long. Regarding the relaxation of scalp tension, it is clear that thinning hair is not due to scalp tension, because the thinning of the scalp is not observed when the unsheared temporal scalp is transferred to the thinning frontal region. (Reference 1, P ... 89). Regarding blood circulation promotion, it is difficult to obtain a substantial effect by the blood circulation promoting component that should contribute to hair growth, because even when the amount of percutaneously absorbed drug is decomposed or barely reaches the blood vessel, it is fogged in the bloodstream. (Reference 5).

副腎皮質ホルモンは唯一、医薬品であるミノキシジルと同等の作用を薄毛改善においてみせるとされるが、その育毛効果剤への添加は認められていない。したがってそれに代わり得る成分は、利用に便利即ち液剤におけるような「衣類の汚れ」、「適用の度の整髪手間」を懸念しなくてすむ剤型での調整が課題となる。
本発明は、頭部以外の身体部位に適用し吸収率アップがはかり得る育毛効果粉末剤を以て、この課題を解決しようとするものである。
Adrenocortical hormones are the only drugs that have the same action as minoxidil, a medicinal product, in improving thinning hair, but they have not been added to hair-restoring agents. Therefore, the component which can replace it becomes a problem in terms of adjustment in a dosage form which is convenient for use, that is, it does not have to worry about “dirt of clothing” and “shampooing work each time of application”.
The present invention is intended to solve this problem with a hair-growth effect powder that can be applied to a body part other than the head to increase the absorption rate.

参考文献5Reference 5

「薬物の経皮デリバリーと経皮吸収の促進」薬学雑誌Vol120(2000)P…328"Promoting transdermal delivery and absorption of drugs" Pharmaceutical Journal Vol120 (2000) P ... 328

課題を解決するための手段Means for solving the problem

本発明については従来、頭皮緊張緩和成分や血行促進成分等に置かれてきた育毛効果の期待を、副腎皮質機能を賦活、促進するウコギ科人参葉茎部抽出物又はモクレン科チョウセンゴミシ抽出物に置き、それを外用粉末剤に配合し、経皮吸収率が高い腋下部や陰のう部に汗臭防止を兼ね適用できるようにすることで課題を解決している。Regarding the present invention, the expectation of the hair growth effect that has been placed on the scalp tension relieving component, the blood circulation promoting component, etc., in the sorghum ginseng leaf stem extract or the magnoliaceae ginseng extract that activates and promotes the adrenal cortex function. The problem is solved by putting it in an external powder and applying it to the lower part of the heel and the genital area where the percutaneous absorption rate is high to prevent sweat odor.

ウコギ科人参葉茎部は、副腎皮質ホルモンの血中値低下(慢性的副腎皮質機能低下による)…アジソン病…に用いられ有効であり(参考文献6)モクレン科チョウセンゴミシ果実は、そのエーテル等有機溶媒抽出物に副腎皮質機能促進の働きがあるとされている(参考文献7)。The ginseng leaf stem is effective in reducing blood levels of adrenocortical hormones (due to chronic adrenocortical function decline) ... Addison's disease ... (reference 6) It is said that the organic solvent extract has a function of promoting adrenocortical function (Reference Document 7).

参考文献References

「中薬与免疫」廣東科技術出版、P…123“Chinese medicine immunity”, Pingtung University Technology Publishing, P… 123

参考文献References

「漢薬の臨床応用」医歯薬出版、P…381“Clinical application of Chinese medicine”, medical and dental publishing, P… 381

発明の効果The invention's effect

育毛効果剤の適用は、前記ミノキシジルのように、多毛、軟毛の硬毛化、毛髪径増大の結果を得るのに必ずしも頭部への外用を要さない(参考文献2)。しかも従来の育毛効果剤は、ほとんどが液剤であったため衣類等の汚れや、用後の整髪という不便さがあり、配合成分の経皮吸収率の低さと共に継続使用と効果発現を妨げてきた。
本発明は、副腎皮質ホルモン機能を賦活及び促進する植物由来成分を粉体に吸着させ、汗臭防止を兼ね頭部以外の身体部位に外用する。そのため従来技術品に比べ適用の時が自由に選べる。又液剤ではないので用後、衣類等の汚れはなく、整髪の手間も要らず、何よりも経皮吸収率が向上し育毛効果の好転に役立つ。
The application of the hair-growth effect agent does not necessarily require external application to the head in order to obtain the results of hirsutism, vellus hair thickening, and hair diameter increase as in the case of minoxidil (Reference Document 2). Moreover, since most conventional hair-growth effect agents were liquids, there were inconveniences such as dirt on clothes and hair styling after use, and hindered continuous use and expression of effects along with the low percutaneous absorption rate of the ingredients. .
In the present invention, a plant-derived component that activates and promotes adrenocortical hormone function is adsorbed to a powder, and it is applied externally to a body part other than the head to prevent sweat odor. Therefore, the time of application can be freely selected as compared with the prior art products. In addition, since it is not a liquid agent, there is no dirt on clothes after use, no need for hair styling, and above all, the percutaneous absorption rate is improved, which helps to improve the hair-growth effect.

ウコギ科人参葉茎部を約10倍の重量の水に、また別にモクレン科チョウセンゴミシ果実部を、薄く焦げ目がつく程度に焙じ、約10倍の重量のエーテル又はエタノール等有機溶媒にそれぞれ24時間浸漬、ろ過し、各公知の方法で蒸発乾固し、別々に粉砕微粒化する。これら抽出物を用い実施例の処方で粉末剤をつくる。これを起床時、就寝前、又は随時に腋下、陰のう部、着用の下着等に撒布し続けると、液状育毛効果剤の頭部塗布の場合のような煩わしさなく、所望の育毛効果を得ることができる。なお本発明における各抽出物配合量は、一種類の配合で0.5〜2.5重量%、二種類配合の場合は合計で1.0〜4.0重量%を好適とする。Ginseng leaves and stems are roasted to about 10 times the weight of water, and the magnoliaceae ginseng fruit is thinly burnt to an extent that is about 10 times the weight in an organic solvent such as ether or ethanol for 24 hours. Immerse and filter, evaporate to dryness by each known method, and pulverize and atomize separately. Using these extracts, a powder is prepared according to the formulation of the example. If this is kept on waking up, before going to bed, or at any time on the armpit, genital area, wearing underwear, etc. Can be obtained. In addition, each extract compounding amount in the present invention is preferably 0.5 to 2.5% by weight for one kind of compounding, and 1.0 to 4.0% by weight in the case of two kinds of compounding.

以下、それぞれ実施例処方に従って本発明の効果を説明する。但し本発明は以下の実施例に何ら限定を受けるものではない。Hereinafter, the effects of the present invention will be described in accordance with each example formulation. However, the present invention is not limited to the following examples.

粉末エアゾール剤…以下の処方の混合物30%にLPG70%を合してつくる

Figure 2009215274
Powder aerosol ... Made with 30% LPG and 70% LPG.
Figure 2009215274

粉末シート剤…以下の処方のローションを不織布に含浸させ水分をきって適当な大きさ(例…1cm4方)に裁断し、頭部以外の部位を清拭する。

Figure 2009215274
Figure 2009215274
Powder sheet agent: A non-woven fabric is impregnated with a lotion having the following formulation, and water is removed to cut it into an appropriate size (eg, 1 cm 4), and the parts other than the head are wiped off.
Figure 2009215274
Figure 2009215274

対照…粉末エアゾール剤、粉末シート剤の処方から、人参葉茎部抽出物、チョウセンゴミシ抽出物を除いた粉末エアゾール剤、粉末シート剤を別につくり対照に用いる。Control: A powder aerosol or powder sheet excluding ginseng leaf stem extract and ginseng extract from the formulation of powder aerosol and powder sheet is prepared separately and used as a control.

本発明に関わる育毛効果粉末剤においては、実施例各配合原料の他に通常医薬部外品、化粧品、食品等に用いられる公知の各種原料、添加物、香料等を適宜任意に用いても差支えない。In the hair-growth effect powder agent according to the present invention, various known raw materials, additives, fragrances and the like which are usually used in quasi-drugs, cosmetics, foods, etc. in addition to the respective ingredients of the examples may be used as appropriate. Absent.

(試験例)
26〜39才の頭頂部頭髪疎少化(薄毛化)が視認される男性4人ずつ3グループを対象に、頭頂部に画定した半径0.8ミリの円内頭髪数を第三者が計数し、3ヶ月の試験前後のそれを比較した(各自、左右の耳を結ぶ線と鼻梁を頭頂にさかのぼる線の交点を中心とした円、半径0.8ミリの円を切り抜いた貼付シートを貼って位置を画定する。実施例対照例共適用部位は臍下、下腹部)結果を表に示す。
(Test example)
A third party counts the number of hairs in a circle with a radius of 0.8 mm defined in the top of the head for three groups of four men each with a view of thinning (thinning hair) of the parietal head between 26-39 years old The results were compared before and after the test for 3 months. (Attach a patch sheet with a circle centered at the intersection of the line connecting the left and right ears and the line extending from the nose bridge back to the top of the head to a radius of 0.8 mm. The results are shown in the table.

試験前後で頭髪本数が5倍増以上となったものを「有効」、2〜4倍増となったものを「やや有効」、増加が認められなかったものを「無効」とした。

Figure 2009215274
“Effective” indicates that the number of hairs increased by 5 times or more before and after the test, “slightly effective” indicates that the number of hair increased by 2 to 4 times, and “invalid” indicates that no increase was observed.
Figure 2009215274

試験例結果の表にみるように、本発明育毛効果粉末剤は従来の育毛効果液剤に比べ、適用部位を頭部以外に選ぶことが出来る。又衣類等を汚すおそれや、用後整髪の必要もなく、随時簡便に用いることができ育毛の効果もあきらかである。As seen in the table of test example results, the hair growth effect powder of the present invention can select the application site other than the head compared to the conventional hair growth effect solution. In addition, there is no risk of soiling clothes or the like, and there is no need for hair styling after use, and it can be used conveniently at any time, and the effect of hair growth is obvious.

Claims (2)

頭部以外の身体部位に適用する育毛効果粉末剤Hair growth effect powder applied to body parts other than the head 育毛効果がウコギ科植物人参の葉茎部、モクレン科植物チョウセンゴミシの果実部からなる群から選ばれた一種以上の抽出物の配合によるものである請求項1の粉末剤2. The powder preparation according to claim 1, wherein the hair-growth effect is obtained by blending one or more extracts selected from the group consisting of a leaf stem portion of a carrot family ginseng and a fruit part of a magnoliaceae plant ginseng.
JP2008100840A 2008-03-11 2008-03-11 Powdery hair growth agent applied to various spots of body except head Pending JP2009215274A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008100840A JP2009215274A (en) 2008-03-11 2008-03-11 Powdery hair growth agent applied to various spots of body except head

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008100840A JP2009215274A (en) 2008-03-11 2008-03-11 Powdery hair growth agent applied to various spots of body except head

Publications (1)

Publication Number Publication Date
JP2009215274A true JP2009215274A (en) 2009-09-24

Family

ID=41187515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008100840A Pending JP2009215274A (en) 2008-03-11 2008-03-11 Powdery hair growth agent applied to various spots of body except head

Country Status (1)

Country Link
JP (1) JP2009215274A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8810172B2 (en) 2010-05-31 2014-08-19 Denso Corporation Motor control apparatus, valve timing regulating apparatus and inverter circuit energization method
CN103989951A (en) * 2014-06-01 2014-08-20 肖红梅 Traditional Chinese medicine composition for treating chronic tonsillitis caused by lung yin deficiency
CN104800741A (en) * 2015-05-11 2015-07-29 王永妍 Nourished ant wine and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8810172B2 (en) 2010-05-31 2014-08-19 Denso Corporation Motor control apparatus, valve timing regulating apparatus and inverter circuit energization method
CN103989951A (en) * 2014-06-01 2014-08-20 肖红梅 Traditional Chinese medicine composition for treating chronic tonsillitis caused by lung yin deficiency
CN104800741A (en) * 2015-05-11 2015-07-29 王永妍 Nourished ant wine and preparation method thereof

Similar Documents

Publication Publication Date Title
CN109846773A (en) A kind of scalp composition and its preparation method and application can inhibit alopecia seborrheica
US20060088497A1 (en) Topical skin care composition
CN105902402A (en) Active mixture
BR0307126B1 (en) Use of purslane to treat facial wrinkles
EP2802331B1 (en) Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
KR101908978B1 (en) A aromatic composition having anti-stress and fatigue relaxing, and a cosmetic composition containing the same
CN107530258A (en) For promoting hair growth or hair reparation and composition for anti-inflammatory
WO2015089461A1 (en) Exfoliative hair retention-promoting formulation
KR102006950B1 (en) Cosmetics compositions for hair growth promoter
CN104027280B (en) A kind of delay aging drug compositions and the application in cosmetics thereof
CN105555285A (en) Composition for promoting hair sprouting and hair growth
JP5765744B2 (en) Preventive or therapeutic agent for atopic dermatitis, and external preparation
JP2009215274A (en) Powdery hair growth agent applied to various spots of body except head
JP5719519B2 (en) Hair or scalp cosmetic composition
JP5714694B2 (en) Use of dihydrodehydrodiisoeugenol and formulations containing dihydrodehydrodiisoeugenol
KR101472466B1 (en) A pharmaceutical composition and a hair make-up composition for prompt hair-increasing and for treating hair loss
JP2001131045A (en) Cell-activating agent and cosmetic material containing the same
JP3974003B2 (en) Hair growth material and external preparation for skin containing the same
KR20180083782A (en) Cosmetic composition comprising withania somnifera, morus australis and pure tea extracts
US20190125648A1 (en) Composition for preventing, improving or treating hair loss comprising deoxycholic acid as active ingredient
KR101578849B1 (en) Shampoo or conditioner composition containing Ginsenoside C-Mx1 for promoting hair growth by strengthen the scalp and the hair roots
TWI353249B (en) Hair growth agent composition
US20210393720A1 (en) Hair Growth Compositions
US20220133830A1 (en) Topical composition for control of demodex
JP2000178128A (en) Cosmetic for skin and mind